The Journal of Nuclear Medicine - JNM

The Journal of Nuclear Medicine - JNM Founded in 1960, The Journal of Nuclear Medicine is the world’s leading nuclear medicine, molecular i

According to new data announced by Clarivate in the 2020 Journal Citation Reports™ (released in June 2021), JNM ranks third in impact among 134 medical imaging journals worldwide. Impact factor – 10.057
Five-year impact factor – 8.573
Immediacy index – 4.011
Total citations – 32,949
Eigenfactor Score – 0.03249
Article Influence Score – 2.19

Concepts in phase 1 radiopharmaceutical therapy trial designs: Lessons from the SNMMI dose optimization in radiopharmace...
01/20/2026

Concepts in phase 1 radiopharmaceutical therapy trial designs: Lessons from the SNMMI dose optimization in radiopharmaceutical therapy development workshop. https://ow.ly/NmVL50XU2cN

Early quantitative ⁹⁹mTc-PYP SPECT/CT imaging can reliably differentiate ATTR-CM from non–ATTR-CM cases, reducing the ne...
01/19/2026

Early quantitative ⁹⁹mTc-PYP SPECT/CT imaging can reliably differentiate ATTR-CM from non–ATTR-CM cases, reducing the need for a prolonged uptake period, streamlining clinical workflows, and more. https://ow.ly/Htrt50XQ8qW

Can ⁶⁴Cu-LNTH-1363S be used to sensitively and specifically detect FAP+ fibroblasts in mouse models of myocardial infarc...
01/16/2026

Can ⁶⁴Cu-LNTH-1363S be used to sensitively and specifically detect FAP+ fibroblasts in mouse models of myocardial infarction using PET imaging? https://ow.ly/4IIF50XQ8pr

¹⁸F-RCCB6 immuno-PET/CT is a promising imaging approach for diagnosing and monitoring ccRCC lung and extrapulmonary meta...
01/15/2026

¹⁸F-RCCB6 immuno-PET/CT is a promising imaging approach for diagnosing and monitoring ccRCC lung and extrapulmonary metastases. https://ow.ly/jhPR50XQ8o3

Targeting DNA or the cell nucleus with α-emitters may enhance treatment of both microscopic cancer deposits and macrosco...
01/14/2026

Targeting DNA or the cell nucleus with α-emitters may enhance treatment of both microscopic cancer deposits and macroscopic tumors, potentially improving overall clinical outcomes. https://ow.ly/gXv350XU27r

Combination radiopharmaceutical therapy and external beam radiotherapy is feasible and safe in thyroid cancer patients w...
01/12/2026

Combination radiopharmaceutical therapy and external beam radiotherapy is feasible and safe in thyroid cancer patients who are RAI-refractory. https://ow.ly/oqEb50XQ8lU

TSPO-targeted PET imaging complements and extends current approaches to assess vascular inflammation in large-vessel vas...
01/09/2026

TSPO-targeted PET imaging complements and extends current approaches to assess vascular inflammation in large-vessel vasculitis. See how: https://ow.ly/hGZu50XQ8kI.

01/07/2026

Thoughts from the JNM editorial staff: Can we trust artificial intelligence in scientific publishing? https://ow.ly/FWSo50XMxXb

01/06/2026

Radiopharmaceutical therapy: Rapid growth, rising challenges, and the critical need for expertise. https://ow.ly/8S6050XMxUM

New SNMMI/EANM/ACNM procedure standard/procedure guideline on the use of molecular imaging for renal mass characterizati...
01/05/2026

New SNMMI/EANM/ACNM procedure standard/procedure guideline on the use of molecular imaging for renal mass characterization: https://ow.ly/9nuE50XMxSB

Address

Reston, VA
20190

Alerts

Be the first to know and let us send you an email when The Journal of Nuclear Medicine - JNM posts news and promotions. Your email address will not be used for any other purpose, and you can unsubscribe at any time.

Share

Share on Facebook Share on Twitter Share on LinkedIn
Share on Pinterest Share on Reddit Share via Email
Share on WhatsApp Share on Instagram Share on Telegram